JIOH on LinkedIn JIOH on Facebook
  • Users Online: 246
  • Home
  • Print this page
  • Email this page
Home About us Editorial board Ahead of print Current issue Search Archives Submit article Instructions Subscribe Contacts Login 
REVIEW ARTICLE
Year : 2022  |  Volume : 14  |  Issue : 6  |  Page : 531-542

Behavioral outcome of oral midazolam premedication in pediatric dental general anesthesia: A systematic review


1 Pediatric Dentistry Unit, School of Dental Sciences, Universiti Sains Malaysia (USM), Kota Bharu, Kelantan, Malaysia; Kudat Dental Clinic, Ministry of Health (Malaysia), Kudat, Sabah, Malaysia
2 Kudat Dental Clinic, Ministry of Health (Malaysia), Kudat, Sabah, Malaysia
3 Senggarang Dental Clinic, Ministry of Health (Malaysia), Batu Pahat, Johor, Malaysia
4 Conservative Dentistry Unit, School of Dental Sciences, Universiti Sains Malaysia (USM), Kota Bharu, Kelantan, Malaysia
5 Unit of Biostatistics, School of Dental Sciences, Universiti Sains Malaysia (USM), Kota Bharu, Kelantan, Malaysia
6 Pediatric Dentistry Unit, School of Dental Sciences, Universiti Sains Malaysia (USM), Kota Bharu, Kelantan, Malaysia

Correspondence Address:
Dr. Norsamsu Arni Samsudin
Pediatric Dentistry Unit, School of Dental Sciences, Universiti Sains Malaysia (USM), Health Campus, 16150, Kubang Kerian, Kota Bharu, Kelantan
Malaysia
Login to access the Email id

Source of Support: None, Conflict of Interest: None


DOI: 10.4103/jioh.jioh_161_22

Rights and Permissions

Aim: This systematic review explores the postoperative behavior outcomes of oral midazolam (OM) premedication in pediatric dental general anesthesia (DGA). Premedication drug assists in the reduction of negative psychological impact during the general anesthesia induction, thus influence the behavior, particularly in pediatric patients. OM is one of the common premedications given due to its efficacy and well accepted administration. Materials and Methods: This review was registered under the International Prospective Register of Systematic Reviews (PROSPERO). Studies published in the databases including PubMed Central, Cochrane, Web of Science, Google Scholar and others between January 1980 and December 2020 were analyzed using Preferred Reporting Items for Systematic Review and Meta‐analysis (PRISMA) guidelines. Risks of bias and evidence levels were determined on each selected study. Results: Seven out of 6944 studies, were scrutinized for final analysis, which involved a total of 392 children in experimental groups and 89 children in placebo groups. OM had shown both positive and negative behavior outcomes post DGA using different assessment tools, in comparison to other premedications. It also showed less side effect post consumption. Conclusions: OM premedication demonstrated very limited evidence for positive behavior outcomes in pediatric DGA. The 0.5 mg/kg body weight dosage of midazolam yields the most favorable behavior postoperatively. Based on this collective review, there is still limited evidence for positive behavior outcomes in OM premedication.


[FULL TEXT] [PDF]*
Print this article     Email this article
 Next article
 Previous article
 Table of Contents

 Similar in PUBMED
   Search Pubmed for
   Search in Google Scholar for
 Related articles
 Citation Manager
 Access Statistics
 Reader Comments
 Email Alert *
 Add to My List *
 * Requires registration (Free)
 

 Article Access Statistics
    Viewed552    
    Printed24    
    Emailed2    
    PDF Downloaded28    
    Comments [Add]    

Recommend this journal